Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Bipolar Disorder Drugs and Treatment Market
The increasing prevalence of bipolar disorders is supplementing the demand for bipolar disorder drugs and treatment industry. For instance, according to the Johns Hopkins University report, approximately 9.5% of American adults ages 18 and over suffer from a depressive illness (major depression, bipolar disorder, or dysthymia) each year. Women are nearly twice as likely to suffer from major depression than men. Hence, rising cases of bipolar disorder will foster the market growth.
Moreover, several nation’s governments are providing funds for bipolar disorder research and launching awareness programs to remove the stigma attached to the condition and raise treatment & adherence rates among the public. Medical institutions and scientific organizations are also actively participating by conducting research investigations and creating cutting-edge drugs and therapies for bipolar disorder. Such factors will drive the market growth in the forthcoming year.